Location History:
- Ibaraki, JP (2012)
- Osaka, JP (2014)
Company Filing History:
2 out of 3,871 
2 out of 30 Years Active: 2012-2014
Title: Innovations by Katsuyuki Ookubo: A Pioneer in Pharmaceutical Adhesives
Introduction
Katsuyuki Ookubo is a notable inventor based in Osaka, Japan, recognized for his contributions to the field of pharmaceutical preparations. With a total of 2 patents, he has made significant advancements in adhesive pharmaceutical technologies, particularly focusing on bisoprolol.
Latest Patents
One of his latest patents involves an adhesive pharmaceutical preparation containing bisoprolol. This innovative preparation is designed to minimize skin irritation while maintaining excellent stability of bisoprolol. It allows for the continuous administration of a pharmacologically effective amount of bisoprolol into the body. The adhesive preparation consists of a support and an adhesive layer that includes bisoprolol, polyisobutylene, a tackifier, and an organic liquid ingredient compatible with both polyisobutylene and the tackifier. This formulation ensures good adhesiveness with minimal irritation and pain during removal, while also leaving little to no residue on the skin. Another patent focuses on a pressure-sensitive adhesive layer that enhances the compatibility of bisoprolol, allowing for a higher blending amount and improved adhesion characteristics.
Career Highlights
Katsuyuki Ookubo has worked with prominent companies such as Nitto Denko Corporation and Toa Eiyo Ltd. His experience in these organizations has contributed to his expertise in developing innovative adhesive solutions for pharmaceutical applications.
Collaborations
Throughout his career, Ookubo has collaborated with notable colleagues, including Yoshihiro Iwao and Katsuhiro Okada. These partnerships have fostered a collaborative environment that has led to significant advancements in their respective fields.
Conclusion
Katsuyuki Ookubo's work in adhesive pharmaceutical preparations showcases his innovative spirit and dedication to improving patient care through technology. His contributions continue to influence the pharmaceutical industry, paving the way for future advancements.